Address |
1601 Trapelo Road Waltham Massachusetts 02451 United States |
Employees | - |
Website | http://www.minervaneurosciences.com |
Updated | 07/08/2019 |
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA. |